Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Environmental metal exposure significantly contributes to coronary calcium buildup, comparable to traditional cardiovascular ...

Root canal treatment is a common dental procedure aimed at saving damaged or infected teeth. Despite concerns about its ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain ...

Hope Unlimited Ministries will have its annual fundraising event featuring Point of Grace on Thursday, Oct. 17. This event ...

Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...

The number of people with diabetes worldwide continues to rise every year. Diabetes makes people more likely to develop heart ...

New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive ...